Annotation of rs362272

Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.

The authors carried out a GWAS in a Spanish cohort of pediatric patients, than performed a meta-analysis using data from the Spanish cohort and data from a Brazilian adult patient cohort. This variant was not significant in the meta-analysis after Bonferroni correction had been applied, and was nominally significant (i.e did not reach genome-wide significance) in the initial GWAS in the Spanish cohort. Response was measured on the Clinical Global Impression-Improvement scale (CGI-I). A CGI-I score of two points or less after eight weeks of treatment was considered a good response.

Gene

HTT

Variant

rs362272

Phenotype Category

Efficacy

Association Significance

The study reports this association is not significant

PharmGKB ID

1449166325

Evidence for Clinical Annotations

This annotation has been used as evidence for the following clinical annotations.

    Study Parameters

    Study type

    meta-analysis, GWAS

    Study size

    362

    Association p-value

    = 0.324

    Statistical analysis

    OR: 1.34

    Confidence interval

    0.75 - 2.41

    Biogeographical group
    More info on groups

    Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil

    Population description

    children (pediatrics); men; women

    Note: Alleles in PharmGKB are mapped to the positive chromosomal strand. Therefore, variants in genes on the "minus" strand (eg. VKORC1) are complemented in PharmGKB annotations.

    History

    Loading...